Reid Dabney

Reid Dabney has a diverse work experience in various roles and industries. In 2003, they became a Founding Member and Managing Director/Business Development Officer at CFO 911, a group of professionals providing accounting, finance, and operational solutions to companies. In this role, they led new business development activities and served as an Interim CFO, COO, President, and Board Member for client firms. Their responsibilities also included advising and managing client firms through events such as IPOs, restructurings, audits, and M&A transactions.

In 2007, Reid Dabney joined ChromaDex (CDXC) as a Board Member, where they served as the Audit Committee Chair and Compensation Committee member until 2017.

From 2017 to 2019, Reid Dabney worked as a Business Advisor at Deep Knowledge Life Sciences, a venture fund focused on bio-pharmaceutical, precision medicine, and AI healthcare companies. Reid collaborated with scientists and strategically invested in mission-driven companies.

Currently, Reid Dabney holds the position of Managing Director of Investment Banking at Oberon Securities, LLC, a New York-based boutique investment bank. The organization specializes in providing tailored financial solutions to emerging and mid-size businesses across various industries.

Overall, Reid Dabney has a strong background in finance, business development, and advisory roles, with a focus on working with growth-oriented companies and addressing their financial needs.

Reid Dabney holds an MBA in Finance from The Wharton School, which they attended from 1978 to 1980. Prior to that, they obtained a Bachelor of Arts (B.A.) degree in Economics and Literature from Claremont McKenna College, where they studied from 1969 to 1973. Additionally, Reid Dabney has obtained several certifications, including FINRA Series 7, 24, 63, 79 & 99, although the specific details of when and where they obtained these certifications have not been provided.